Impact of abrocitinib on itch, sleep, skin pain and psychological stress in patients with moderate-to-severe atopic dermatitis: pooled analysis from JADE monotherapy trials

被引：0
|
作者：
Bewley, A. [1 ]
Thyssen, J. P. [2 ]
Chiu, W. S. [3 ]
Rojo, R. [4 ]
Biswas, P. [5 ]
Feeney, C. [3 ]
DiBonaventura, M. [5 ]
Misery, L. [6 ]
Stander, S. [7 ]
Cork, M. [8 ]
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Pfizer Ltd, Tadworth, England
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Pfizer Inc, New York, NY USA
[6] Univ Hosp Ctr Brest, Brest, France
[7] Muenster Univ Hosp, Munster, Germany
[8] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
B06
引用
收藏
页码：E72 / E73
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis in the Presence or Absence of Comorbid Asthma or Allergic Rhinitis: A Post Hoc Pooled Analysis of JADE COMPARE and JADE DARE
    Thyssen, Jacob P.
    Silverberg, Jonathan I.
    Yosipovitch, Gil
    Kwatra, Shawn G.
    Carrascosa, Jose-Manuel
    Brunner, Patrick M.
    Lazariciu, Irina
    Feeney, Claire
    Rebollo, Francisco J.
    Koppensteiner, Herwig
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB156 - AB156
  • [22] Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
    Staender, Sonja
    Kwatra, Shawn G.
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Yosipovitch, Gil
    Zhang, Fan
    Cameron, Michael C.
    Cella, Ricardo Rojo
    Valdez, Hernan
    DiBonaventura, Marco
    Feeney, Claire
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (01) : 97 - 107
  • [23] Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan, I
    DeLozier, Amy
    Sun, Luna
    Thyssen, Jacob P.
    Kim, Brian
    Yosipovitch, Gil
    Nunes, Fabio P.
    Gugiu, P. Cristian
    Doll, Helen A.
    Eichenfield, Lawrence F.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2021, 19 (01)
  • [24] Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
    Sonja Ständer
    Shawn G. Kwatra
    Jonathan I. Silverberg
    Eric L. Simpson
    Jacob P. Thyssen
    Gil Yosipovitch
    Fan Zhang
    Michael C. Cameron
    Ricardo Rojo Cella
    Hernan Valdez
    Marco DiBonaventura
    Claire Feeney
    American Journal of Clinical Dermatology, 2023, 24 : 97 - 107
  • [25] Psychometric properties of the itch numeric rating scale, skin pain numeric rating scale, and atopic dermatitis sleep scale in adult patients with moderate-to-severe atopic dermatitis
    Jonathan I. Silverberg
    Amy DeLozier
    Luna Sun
    Jacob P. Thyssen
    Brian Kim
    Gil Yosipovitch
    Fabio P. Nunes
    P. Cristian Gugiu
    Helen A. Doll
    Lawrence F. Eichenfield
    Health and Quality of Life Outcomes, 19
  • [26] Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE
    Silverberg, Jonathan I.
    Simpson, Eric L.
    Pink, Andrew E.
    Weidinger, Stephan
    Chan, Gary
    Biswas, Pinaki
    Clibborn, Claire
    Guler, Erman
    DERMATOLOGY AND THERAPY, 2025, 15 (02) : 367 - 380
  • [27] Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Pink, Andrew E.
    Weidinger, Stephan
    Chan, Gary
    Lazariciu, Irina
    Clibborn, Claire
    Guler, Erman
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [28] Long-term efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis who had failed or were intolerant to oral nonsteroidal immunosuppressants: pooled analysis of JADE clinical trials
    Ardern-Jones, M.
    Ameen, M.
    de Bruin-Weller, M.
    Simpson, E.
    Chiu, W. S.
    Biswas, P.
    Chan, G.
    Koulias, C.
    Weidinger, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E151 - E152
  • [29] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
    Li, Hang
    Cheng, Hao
    Lu, Qianjin
    Lai, Wei
    Tao, Xiaohua
    Encinas, Gerardo A.
    Vyas, Shefali
    Wang, Bo
    Luo, Xin
    Li, Shiqi
    CHINESE MEDICAL JOURNAL, 2024, 137 (16) : 1991 - 1992
  • [30] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
    Li Hang
    Cheng Hao
    Lu Qianjin
    Lai Wei
    Tao Xiaohua
    Encinas Gerardo A
    Vyas Shefali
    Wang Bo
    Luo Xin
    Li Shiqi
    中华医学杂志英文版, 2024, 137 (16)
12345